Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Future of Progressive Multiple Sclerosis Therapies.

Autor: Hollen CW; is Multiple Sclerosis Fellow and is a Neurologist and the Associate Director of Clinical Affairs for the MSCoE-West, both at the VA Portland Health Care System in Oregon. is a Neurologist and the Clinical Director of the MSCoE-West Regional Program at the VA Salt Lake City Health Care System in Utah. is a Neurologist and the Clinic Director of the MS Clinic at the Birmingham VA Medical Center in Alabama., Paz Soldán MM; is Multiple Sclerosis Fellow and is a Neurologist and the Associate Director of Clinical Affairs for the MSCoE-West, both at the VA Portland Health Care System in Oregon. is a Neurologist and the Clinical Director of the MSCoE-West Regional Program at the VA Salt Lake City Health Care System in Utah. is a Neurologist and the Clinic Director of the MS Clinic at the Birmingham VA Medical Center in Alabama., Rinker JR 2nd; is Multiple Sclerosis Fellow and is a Neurologist and the Associate Director of Clinical Affairs for the MSCoE-West, both at the VA Portland Health Care System in Oregon. is a Neurologist and the Clinical Director of the MSCoE-West Regional Program at the VA Salt Lake City Health Care System in Utah. is a Neurologist and the Clinic Director of the MS Clinic at the Birmingham VA Medical Center in Alabama., Spain RI; is Multiple Sclerosis Fellow and is a Neurologist and the Associate Director of Clinical Affairs for the MSCoE-West, both at the VA Portland Health Care System in Oregon. is a Neurologist and the Clinical Director of the MSCoE-West Regional Program at the VA Salt Lake City Health Care System in Utah. is a Neurologist and the Clinic Director of the MS Clinic at the Birmingham VA Medical Center in Alabama.

Publikováno v: Federal practitioner : for the health care professionals of the VA, DoD, and PHS [Fed Pract] 2020 Apr; Vol. 37 (Suppl 1), pp. S43-S49.